Quebec Ocular Melanoma Biobank, Canada

Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Registration Status: Completed

Objective: Ocular melanoma is the most common intraocular malignancy in the adult population. Since familial cases of this cancer are very rare, it is difficult to prevent or detect it. Despite effective treatment of eye tumours, over 50% of patients develop incurable metastases, mainly to the liver, within 15 years of diagnosis of the primary tumour. Around 20 biopsies of ocular tumors are taken in Quebec each year, and the biopsies obtained for research purposes are small. This infrastructure pools biological material from donors suffering from ocular melanoma, combined with a clinical database. Biopsies taken from tumors or metastases are used to culture cell lines and carry out genetic/proteomic/biomechanical studies. This infrastructure plays an important role in the achievement of various research programs for a better understanding of genetic and environmental factors involved in the development of ocular melanoma and the spread of metastasis. It allows collaboration with other researchers at a provincial, national and international level in order to make progress in basic and clinical research on ocular melanoma.

Registered Biobank Name	Quebec Ocular Melanoma Biobank
Biobank Leader	Solange Landreville
Country	Canada
Email for biobank inquiries	Solange.Landreville@fmed.ulaval.ca
Principal Investigator	Solange Landreville
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected: